These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 6413338)

  • 1. [Efficacy of different therapeutic principles in experimental retinal vessel occlusions].
    Wizemann A; Maier T; Wizemann V
    Fortschr Ophthalmol; 1983; 80(2):176-8. PubMed ID: 6413338
    [No Abstract]   [Full Text] [Related]  

  • 2. [Fibrinolysis of retinal vein closures: treatment with urokinase].
    Ohrloff C; Trübestein G; Völker B; Weigelin E
    Fortschr Ophthalmol; 1983; 80(2):162-5. PubMed ID: 6618373
    [No Abstract]   [Full Text] [Related]  

  • 3. Prostacyclin--experimental and clinical approach.
    Gryglewski R
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():457-61. PubMed ID: 6221563
    [No Abstract]   [Full Text] [Related]  

  • 4. [Possible mechanisms of the therapeutic action of laser coagulation in occlusions of the retinal vessels].
    Bochkareva AA; Ivanishko IuA
    Oftalmol Zh; 1984; (7):401-3. PubMed ID: 6543249
    [No Abstract]   [Full Text] [Related]  

  • 5. [Medical treatment of retinal vein thrombosis].
    Algan B
    Bull Soc Belge Ophtalmol; 1982; 201():15-21. PubMed ID: 7187254
    [No Abstract]   [Full Text] [Related]  

  • 6. Endotoxin-induced intravascular coagulation in rabbits: effect of tissue plasminogen activator vs urokinase of PAI generation, fibrin deposits and mortality.
    Paloma MJ; Páramo JA; Rocha E
    Thromb Haemost; 1995 Dec; 74(6):1578-82. PubMed ID: 8772240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analyses of cases of retinal vessel occlusions at the Ophthalmologic Clinic in Sarajevo with special regard to etiology and therapy].
    Mastilović B; Milanović LJ; Hodzić S; Popović M
    Med Arh; 1976; 30(4):225-8. PubMed ID: 1004018
    [No Abstract]   [Full Text] [Related]  

  • 8. Transient ischemic injury in the rat retina caused by thrombotic occlusion-thrombolytic reperfusion.
    Daugeliene L; Niwa M; Hara A; Matsuno H; Yamamoto T; Kitazawa Y; Uematsu T
    Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2743-7. PubMed ID: 10937592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of retinal venous occlusions].
    Arnoux M; Rodossio M
    Bull Soc Ophtalmol Fr; 1980 Oct; 80(10):873-6. PubMed ID: 7449003
    [No Abstract]   [Full Text] [Related]  

  • 10. [Endodiathermy in the treatment of experimental proliferative pseudoretinopathy (first results)].
    Bacin F; Chynoransky M; Fabre C; Kantelip B
    Bull Soc Ophtalmol Fr; 1979 Mar; 79(3):289-93. PubMed ID: 527179
    [No Abstract]   [Full Text] [Related]  

  • 11. Nitroglycerin to treat acute loss of vision.
    Kuritzky S
    N Engl J Med; 1990 Nov; 323(20):1428. PubMed ID: 2122250
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of potentiation and rapid action in models of venous thrombosis in dogs upon combined administration of the plasminogen tissue activator and urokinase modified by fibrinogen].
    Maksimenko AV; Tishchenko EG; Petrova ML; Golubykh VL
    Biull Eksp Biol Med; 1996 Jan; 121(1):48-51. PubMed ID: 8680005
    [No Abstract]   [Full Text] [Related]  

  • 13. [Left ventricular thrombosis after acute myocardial infarction: relationship with thrombolytic therapy and the patency of the "guilty" vessel].
    Pizzetti G; Belotti G; Chierchia SL
    G Ital Cardiol; 1994 Mar; 24(3):253-60. PubMed ID: 8063060
    [No Abstract]   [Full Text] [Related]  

  • 14. [Results of experimental and clinical evaluation of Trental].
    Katsnel'son LA; Mikhaílova NA; Iakovlev AA
    Vestn Oftalmol; 1980; (1):41-4. PubMed ID: 6989087
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experimental aspects of the therapeutic action of urokinase in thromboembolic states].
    Danilenko MV; Stasiuk NS
    Biull Eksp Biol Med; 1981 Mar; 91(3):293-5. PubMed ID: 7018613
    [No Abstract]   [Full Text] [Related]  

  • 16. Adjunctive therapy to thrombolysis in acute myocardial infarction.
    George BS
    J Invasive Cardiol; 1990; 2(1):41-4. PubMed ID: 10148966
    [No Abstract]   [Full Text] [Related]  

  • 17. [A rat middle cerebral artery thrombosis model for evaluation of thrombolytic and antithrombotic agents].
    Liu XG; Xu LN
    Yao Xue Xue Bao; 1995; 30(9):662-7. PubMed ID: 8701741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Retinal vascular closure using laser photocoagulation].
    Riss JM
    Chirurgie; 1996; 121(4):309-16. PubMed ID: 8945818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in vessel wall plasminogen activator activity and smooth muscle cell proliferation and activation after arterial injury.
    More RS; Underwood MJ; Brack MJ; de Bono DP; Gershlick AH
    Cardiovasc Res; 1995 Jan; 29(1):22-6. PubMed ID: 7895234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Both tissue-type plasminogen activator and urokinase prevent intraabdominal abscess formation after surgical treatment of peritonitis in the rat.
    Buyne OR; van Goor H; Bleichrodt RP; Verweij PE; Hendriks T
    Surgery; 2008 Jul; 144(1):66-73. PubMed ID: 18571586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.